{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:43:39Z","timestamp":1765233819010,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jns.2024.123110","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T01:57:04Z","timestamp":1719194224000},"page":"123110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and validation of a claims-based algorithm to identify patients with Neuromyelitis Optica Spectrum disorder"],"prefix":"10.1016","volume":"463","author":[{"given":"Anisha M.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Exuzides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Yermilov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Dalglish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah N.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila R.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunice","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb","family":"Paydar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Cohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Mayo Clinic Staff","key":"10.1016\/j.jns.2024.123110_bb0005"},{"key":"10.1016\/j.jns.2024.123110_bb0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4103\/1673-5374.179048","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases","volume":"11","author":"Yokote","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jns.2024.123110_bb0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.msard.2018.12.011","article-title":"Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis\/preventive treatment, MRI lesion length and presence of symptomatic brain lesions","volume":"28","author":"Mealy","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2024.123110_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102542","article-title":"Neuromyelitis optica spectrum disorder in China: quality of life and medical care experience","volume":"46","author":"Huang","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2024.123110_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123110_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Yung Hor","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2024.123110_bb0040","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123110_bb0045","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123110_bb0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jclinepi.2010.10.006","article-title":"Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data","volume":"64","author":"Benchimol","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jns.2024.123110_bb0055","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jclinepi.2011.01.001","article-title":"Administrative database research infrequently used validated diagnostic or procedural codes","volume":"64","author":"van Walraven","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jns.2024.123110_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1472-6963-6-77","article-title":"Identifying priorities in methodological research using ICD-9-CM and ICD-10 administrative data: report from an international consortium","volume":"6","author":"De Coster","year":"2006","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.jns.2024.123110_bb0065","first-page":"1697","article-title":"Health services research: reporting on studies using secondary data sources","volume":"155","author":"Huston","year":"1996","journal-title":"CMAJ Can. Med. Assoc. J."},{"author":"Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Oncology Center of Excellence","key":"10.1016\/j.jns.2024.123110_bb0070"},{"key":"10.1016\/j.jns.2024.123110_bb0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2017.11.022","article-title":"Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica","volume":"384","author":"Ajmera","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123110_bb0080","series-title":"Identifying patients with neuromyelitis optica spectrum disorder in US insurance claims database from 2001 To 2007 (2019) Poster Presented at ECTRIMS September 2019","first-page":"408","author":"Costantino","year":"2024"},{"key":"10.1016\/j.jns.2024.123110_bb0085","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/13696998.2021.1917421","article-title":"Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database","volume":"24","author":"Exuzides","year":"2021","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.jns.2024.123110_bb0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 Revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2024.123110_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2024.123110_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.jns.2024.123110_bb0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J. Clin. Epidemiol."},{"author":"Glisson","key":"10.1016\/j.jns.2024.123110_bb0110"},{"key":"10.1016\/j.jns.2024.123110_bb0115","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"Ghali, for the IMECCHI investigators, assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database: assessing validity of ICD-9-CM and ICD-10","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.jns.2024.123110_bb0120","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/jnnp-2020-323158","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK","volume":"91","author":"O'Connell","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2024.123110_bb0125","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol","year":"2020","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"key":"10.1016\/j.jns.2024.123110_bb0130","doi-asserted-by":"crossref","unstructured":"C. Walton, R. King, L. Rechtman, W. Kaye, E. Leray, R.A. Marrie, N. Robertson, N. La Rocca, B. Uitdehaag, I. van der Mei, M. Wallin, A. Helme, C. Angood Napier, N. Rijke, P. Baneke, Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition, Mult. Scler. Houndmills Basingstoke Engl. 26 (2020) 1816\u20131821. doi:https:\/\/doi.org\/10.1177\/1352458520970841.","DOI":"10.1177\/1352458520970841"},{"key":"10.1016\/j.jns.2024.123110_bb0135","first-page":"59","article-title":"Worldwide incidence and prevalence of NMO: A systematic review","author":"Papp","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123110_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jns.2009.08.045","article-title":"Neuromyelitis optica: effect of gender","volume":"286","author":"Wingerchuk","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123110_bb0145","article-title":"Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder","volume":"427","author":"Exuzides","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123110_bb0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s40120-021-00253-4","article-title":"Neuromyelitis optica spectrum disorder: clinical burden and cost of relapses and disease-related care in US clinical practice","volume":"10","author":"Royston","year":"2021","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jns.2024.123110_bb0155","article-title":"The costs of care from a US claims database in patients with neuromyelitis optica spectrum disorder","volume":"427","author":"Exuzides","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123110_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40120-021-00311-x","article-title":"Evaluating the economic burden of relapses in neuromyelitis optica spectrum disorder: a real-world analysis using German claims data","volume":"11","author":"Knapp","year":"2022","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jns.2024.123110_bb0165","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123110_bb0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/08916934.2014.883501","article-title":"A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica","volume":"47","author":"Iyer","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jns.2024.123110_bb0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2024.123110_bb0180","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder: patient experience and quality of life","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"author":"Billing and Coding","key":"10.1016\/j.jns.2024.123110_bb0185"},{"author":"Genentech","key":"10.1016\/j.jns.2024.123110_bb0190"},{"key":"10.1016\/j.jns.2024.123110_bb0195","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12913-017-2340-y","article-title":"Centers of excellence in healthcare institutions: what they are and how to assemble them","volume":"17","author":"Elrod","year":"2017","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.jns.2024.123110_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103884","article-title":"Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy","volume":"63","author":"Orlandi","year":"2022","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24002454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24002454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:48:21Z","timestamp":1761785301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24002454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":39,"alternative-id":["S0022510X24002454"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123110","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a claims-based algorithm to identify patients with Neuromyelitis Optica Spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123110"}}